The Participatory Approach: A Specific French Organizational Model at the Department Level to Serve the Quality of Work Life of Healthcare Providers and the Quality of Care in Pediatric Oncology

Autor: Lejeune J, Fouquereau E, Chênevert D, Coillot H, Chevalier S, Gillet N, Michon JM, Gandemer V, Colombat P

Publikováno v: Cancer Management and Research, Vol Volume 13, Pp 2763-2771 (2021)

Julien Lejeune,1 Evelyne Fouquereau,2 Denis Chênevert,3 Helene Coillot,2 Severine Chevalier,2 Nicolas Gillet,2 Jean M Michon,4 Virginie Gandemer,5 Philippe Colombat2 1Service d’Onco-Hématologie Pédiatrique, Hôpital Clocheville, Tours, France; 2

Externí odkaz: https://doaj.org/article/9e09ee38f65e4b62b7eee3824cec9823

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation.

Autor: Spreafico F; Deptartment of Medical Oncology and Hematology, Pediatric Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. filippo.spreafico@istitutotumori.mi.it., Dalissier A; EBMT Paris Study Office/CEREST-TC, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Paris, France., Pötschger U; St. Anna Kinderspital, Stem Cell Transplantation Unit, Vienna, Austria., Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome, Rome, Italy., Michon JM; Children, Adolescent and Young Adults Department, Institut Curie, Paris, France., Peters C; St. Anna Kinderspital, Stem Cell Transplantation Unit, Vienna, Austria., Bader P; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany., Bisogno G; Hematology Oncology Division, Department of Woman's and Child's Health, University of Padova, Padova, Italy., Yeomanson D; Sheffield Children's Hospital Western Bank, Sheffield, UK., Willasch A; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany., van den Heuvel Eibrink M; Princess Máxima Centre for Pediatric Oncology, Utrecht, the Netherlands., Graf N; Department of Haematology and Oncology, Saarland University Hospital, Homburg, Germany., Dallorso S; IRCCS Istituto Giannina Gaslini, Genova, Italy.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2020 Feb; Vol. 55 (2), pp. 376-383. Date of Electronic Publication: 2019 Sep 18.

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.

Autor: Ladenstein R; St Anna Children's Hospital, Vienna, Austria; Department for Studies and Statistics and Integrated Research, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria. Electronic address: ruth.ladenstein@ccri.at., Pötschger U; Department for Studies and Statistics and Integrated Research, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria., Valteau-Couanet D; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France., Luksch R; Department di Ematologica e Onco-Ematologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Castel V; Pediatric Oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain., Yaniv I; Pediatric Oncology Unit, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine Tel Aviv University, Petach Tikvah, Israel., Laureys G; Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent, Ghent, Belgium., Brock P; Department of Pediatric Oncology, Great Ormond Street Hospital, London, UK., Michon JM; Children, Adolescent and Young Adults Department, Institut Curie, Paris, France., Owens C; Department of Haemato-Oncology, Our Lady's Children's Hospital, Dublin, Ireland., Trahair T; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia., Chan GCF; Department of Paediatrics & Adolescent Medicine, Queen Mary Hospital, Hong Kong., Ruud E; Department of Paediatric Medicine, Rikshospitalet, Oslo, Norway., Schroeder H; Department of Paediatrics, University Hospital of Aarhus, Aarhus, Denmark., Beck Popovic M; Department of Paediatrics and Paediatric Surgery, Paediatric Haematology Oncology Unit, University Hospital Lausanne, Switzerland., Schreier G; Centre for Health and Bioresources, AIT Austrian Institute of Technology GmbH, Graz, Austria., Loibner H; Apeiron Biologics AG, Vienna, Austria., Ambros P; Department of Biology, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria., Holmes K; Department of Paediatric Surgery, St George's Hospital, London, UK., Castellani MR; Department di Ematologica e Onco-Ematologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gaze MN; Department of Oncology, University College London Hospitals NHS Foundation Trust, National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK., Garaventa A; Oncology Unit, Istituto Giannina Gaslini, Genoa, Italy., Pearson ADJ; Paediatric and Adolescent Drug Development Team, Oak Centre for Children and Young People, Institute of Cancer Research, Royal Marsden Hospital, Sutton, UK., Lode HN; Paediatric Haematology-Oncology Department, University Medicine Greifswald, Greifswald, Germany.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2018 Dec; Vol. 19 (12), pp. 1617-1629. Date of Electronic Publication: 2018 Nov 12.

The International Neuroblastoma Risk Groups (INRG): a preliminary report.

Autor: Castleberry RP; Children's Hospital of Alabama, Birmingham, USA., Pritchard J, Ambros P, Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B, Dicks-Mireaux C, Frappaz D, Haase GM, Haber M, Jones DR, Joshi VV, Kaneko M, Kemshead JT, Kogner P, Lee RE, Matthay KK, Michon JM, Monclair R, Roald BR, Seeger RC, Shaw PJ, Shuster JJ, et. al.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 1997 Oct; Vol. 33 (12), pp. 2113-6.